Advertisement
Exelixis, Inc.

Exelixis, Inc. (EXEL) Stock Overview

Explore Exelixis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EXELNASDAQ
HealthcareBiotechnology
$55.55
$0.22(0.39%)
U.S. Market opens in 16h 12m
Advertisement

Exelixis, Inc. (EXEL)

Meyka AI Score

Z

Key Financials

Market Cap14B
P/E Ratio17.84
EPS (TTM)$3.34
ROE0.40%
Fundamental Analysis

AI Price Forecasts

1 Month$49.80
3 Months$48.04
1 Year Target$55.82

EXEL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Exelixis, Inc. (EXEL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.84 and a market capitalization of 14B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.39%
5-Day Change
-2.87%
1-Month Change
4.81%
3-Month Change
25.45%
6-Month Change
22.25%
Year-to-Date (YTD) Change
26.74%
1-Year Change
26.08%
3-Year Change
189.47%
5-Year Change
219.07%
All-Time (Max) Change
276.61%

Contact Information

650 837 7000
1851 Harbor Bay Parkway, Alameda, CA, 94502

Company Facts

11,470 Employees
IPO DateApr 17, 2000
CountryUS
Actively Trading

Frequently Asked Questions